Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Post concerning Biel has been surveyed and the Survey Says
Pure BS
That Pesky FDA thing is COMING!!!
Stack that on top of what is a profitable company Q1
In 7 Years the company has NEVER lied
Please note initial order has been placed, may not be up and running just yet.
BioElectronics Expands in the UK Market
Leading UK Retailer, Superdrug to market and sell ActiPatch® Pain Therapy
Google+ Share with LinkedIn
FREDERICK, Md., Nov. 9, 2015 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that it has received an initial order for its ActiPatch® Musculoskeletal Pain Relief products from Superdrug pharmacies. Superdrug is a subsidiary of the A.S. Watson Group, the world's largest international health and beauty retailer with 12,000 stores. Superdrug will promote BioElectronics' 7-Day Trial Device, Try & Tell Marketing Campaign online and stock ActiPatch in 186 stores in mid-November.
"Superdrug will promote BioElectronics 7-Day Trial Device, to create product demand on their web site," said Ben Fichter, Marketing Director, BioElectronics Corporation. "We are looking forward to collaborating with this innovative retailer to extend our successful marketing program into the retail environment."
Fichter explained that Superdrug will offer the 7-Day trial version of ActiPatch Therapy for about $5 US to attract new chronic pain customers. "Based on prior results, using this marketing program, we expect the majority of consumers who buy the trial unit to later buy more than 2 full price units," Fichter said. "The customer survey aspect of the program will help BioElectronics and Superdrugs marketing staff better understand the chronic pain management needs of consumers." To date, the program has had exceptional consumer acceptance and in the reduction of pain and improvements in the quality of life.
About Superdrug Pharmacy
Superdrug (www.superdrug.com) is the United Kingdom's second-largest beauty and health retailer currently operating more than 800 stores in England, Scotland, Wales, Northern Ireland and the Republic of Ireland with 200 in-store pharmacies.
A.S.Watson Limited is one of the oldest and best-known trading names in Asia. Founded in 1828, the A.S. Watson Group (ASW) is a retail and manufacturing business with operations in 24 markets worldwide and is a wholly-owned subsidiary of Hong Kong-based conglomerate C.K. Hutchison Holdings. Worldwide A.S. Watson operates more than 12,000 retail stores and duty-free airport shops selling health and beauty products, luxury perfumes, cosmetics, electronics, gourmet foods and fine wine.
Contact: Superdrug press office at ZPR on 0207 896 3404 or email superdrug@z-pr.com
About BioElectronics Corporation
BioElectronics Corporation is the maker of a leading family of affordable, disposable, drug-free, anti-inflammatory medical devices. The product brands include: ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; the Allay® Menstrual Pain Therapy and HealFast® Therapy for veterinary applications. Please visit www.bielcorp.com for more information.
Contact:
Paul Knopick, 940.262.3584
pknopick@eandecommunications.com
SOURCE BioElectronics Corporation
Just got traction this year Profit Q1 2016
MASSIVE GAPPER ONE DAY SOON BOOM and CHASE
if you are not in before it happens which no one can accurately predict when it will happen.
FDA BOOM
PARTNER or LICENSING BOOM
B BRAUN kicks in BOOM
I am in and waiting
all imo
Must be confused by the post. This is an increase that helps Biel get to Profitability. Went from 31o stores and are at 2511 stores for the year. Now the question is how many more stores will be added next year. Certainly more then 100%. Maybe 1000% or more.
Not true, buys that market makers have to "true up" at the end of the day.
Post is purely a rearview mirror view of Biel Look out the windshield and see the 2511 stores up from 310 stores. Look at when B Braun kicks in, oh and look at that PESKY FDA Clearance THINGY!!!
News is out for new Stores in Canada
BioElectronics' ActiPatch® Pain Therapy Available at 102 Showcase Stores in Canada
[07-December-2015]
FREDERICK, Md., Dec. 7, 2015 /PRNewswire/ -- BioElectronics Corporation (OTC Pink: BIEL), the maker of advanced consumer pain management medical devices, today announced that its Canadian distributor, Chris-Kelly LLC, has shipped the initial stocking order to Showcase Stores.
Chris Russell, President, Chris-Kelly, LLC, stated, "We are excited to have a retail partner like Showcase only eight months after debuting ActiPatch in Canada. ActiPatch is now available in Showcase's 102 stores across Canada." Amin Jivraj, Founder of Showcase, stated, "At Showcase, we bring to consumers emerging trends in health, beauty, and home, all in an environment where you can 'try it before you buy it.' ActiPatch offers an ingenious solution to pain relief, and we are proud to introduce it to our customers across Canada."
About Showcase Stores
Showcase (www.shopatshowcasecanada.com) is the Home of the Hottest Trends, and the world's largest retailer of its kind. With 100+ permanent stores in Canada's best shopping centres, Showcase offers the most fun, interactive, new, and unique products ever. Founded in 1994 in Edmonton AB, Showcase now is coast-to-coast in every major market across Canada.
About BioElectronics Corporation
BioElectronics Corporation is the maker of a leading family of affordable, disposable, drug-free, medical devices. ActiPatch® Therapy, over-the-counter treatment for back pain and other musculoskeletal complaints; RecoveryRx® Devices for chronic and post-operative wound care; HealFast® Therapy and the Allay® Menstrual Pain Therapy. Please visit www.bielcorp.com for more information.
Contact:
Paul Knopick
940.262.3584
pknopick@eandecommunications.com
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/bioelectronics-actipatch-pain-therapy-available-at-102-showcase-stores-in-canada-300188841.html
SOURCE BioElectronics Corporation
Talking about Biel that breaks even and turns a profit Q1
Post is pure EVIL distortion of the TRUTH
Then there is that PESKY FDA Clearance thingy!!
To Report Fraudulent Statements Against BIEL Contact:
Office of the Whistleblower, SEC,
100 F Street, NE, Mail Stop 5971, Washington, DC 20549
(800) 732-0330
by fax:(703) 813-9322
Updated Investor Alert: Social Media and Investing -- Stock Rumors
Nov. 5, 2014
The U.S. Securities and Exchange Commission’s (SEC) Office of Investor Education and Advocacy (“OIEA”) is issuing this Investor Alert to warn investors about fraudsters who may attempt to manipulate share prices by using social media to spread false or misleading information about stocks.
Social media and the Internet in general have become important tools for investors. Investors may use social media to research particular stocks, look up background information on a broker-dealer or investment adviser, find guidance on investing strategies, receive up-to-date news, and discuss the markets with others.
While social media can provide many benefits for investors, it also presents opportunities for fraudsters. Through social media, fraudsters can spread false or misleading information about a stock to large numbers of people with minimum effort and at a relatively low cost. They can also conceal their true identities by acting anonymously or even impersonating credible sources of market information.
One way fraudsters may exploit social media is to engage in a market manipulation, such as spreading false and misleading information about a company to affect the stock’s share price. Wrongdoers may perpetuate stock rumors on social media, as well as on online bulletin boards and in Internet chat rooms.
The false or misleading rumors may be positive or negative. For example, in a “pump-and-dump” scheme, promoters “pump” up the stock price by spreading positive rumors that incite a buying frenzy and they quickly “dump” their own shares before the hype ends. Typically, after the promoters profit from their sales, the stock price drops and the remaining investors lose money. In other instances, fraudsters start negative rumors urging investors to sell their shares so that the stock price plummets and the fraudsters take advantage of buying shares at the artificially low price.
SEC Enforcement Action Involving Social Media and Market Manipulation
The SEC has charged individuals for committing securities fraud through the use of social media.
In a recent Enforcement action, SEC v. Craig, the SEC accused an individual of manipulating the share prices of two publicly traded companies by tweeting false and misleading information. The defendant allegedly tweeted rumors that federal law enforcement was investigating a technology company for fraud, and that a biopharmaceutical company had tainted drug trial results and a federal government agency seized its papers. The SEC asserted that these deceptive tweets were made from Twitter accounts mimicking established securities research firms. The hoaxes allegedly caused investors to lose more than $1.5 million.
In SEC v. McKeown and Ryan, the SEC obtained judgments against a Canadian couple who used their website (PennyStockChaser), Facebook, and Twitter to pump up the stock of microcap companies, and then profited by selling shares of those companies. The couple allegedly received millions of shares of these companies as compensation and sold the shares around the time that their website predicted the stock price would massively increase (a practice known as “scalping”). The SEC’s complaint alleged that the couple did not fully disclose the compensation they received for touting the stocks. The court ordered the couple and their companies to pay more than $3.7 million in disgorgement for profits gained as a result of the alleged conduct, and ordered the couple to pay $300,000 in civil penalties.
Investors should be aware that fraudsters may use social media to impersonate an established source of market information. For example, fraudsters may set up an account name, profile, or handle designed to mimic a particular company or securities research firm. They may go so far as to create a webpage that uses the company’s logo, links to the company’s actual website, or references the name of an actual person who works for the company.
When you receive investment information through social media, verify the identity of the underlying source. Look for slight variations or typos in the sender’s account name, profile, email address, screen name, or handle, or other signs that the sender may be an imposter. Determine whether information appearing to be from a particular company or securities research firm is authentic. When contacting a company or attempting to access its website, be sure to use contact information or the website address provided by the company itself, such as in the company’s SEC filings. Carefully type the website’s address into the address bar of your web browser.
MASSIVE GAPPER ONE DAY SOON BOOM and CHASE
if you are not in before it happens which no one can accurately predict when it will happen.
FDA BOOM
PARTNER or LICENSING BOOM
B BRAUN kicks in BOOM
I am in and waiting
all imo
NICE VIEW in the rearview mirror but looking out the windshield the view shows an emerging monster named Biel!!!
Don't forget that PESKY FDA thingy!!
The Explosion in stores and sales have NOT been recorded yet but will be showing up in Q1 2016 but then it does not take a rocket scientist to know that, or does it?
Have you seen the explosion in sales and the tremendous growth in stores? You need to look at ALL the very recent growth that will SOON be recognized!!
And that VERY PESKY FDA thingy!!
DING DING DING we have a winning post about Biel with CORRECT information!!
All you need do is wait for the results of Q1
Profit Q1
oh and that PESKY FDA thingy!!!
To appreciate just how UNDERVALUED Biel currently is and considering we know it will be profitable shortly, go look at 10 random bio tech companies Market Caps and THAT will show you just how much HIGER this is going with FDA approval.
This company will have a Market Cap of 150 Million minimum with FDA approval imo
11 million Market Cap is Peanuts for a start up transitioning to a real and profitable company.
Buy BUY BUY signal
****** SECOND******* BOARD ******* WARNING ******* ALERT *******
Prepare for the Ascent.
Do not be deterred by negative posts.
Biel is going Profitable Q1 2016 in 5 weeks.
FDA is pending and virtually in the bag!!
2511 Stores will be selling products at least to start Q1.
This has been a public service announcement in support of all
BIELIES BIELIVERS !!
Prepare for the Ascent Buy Now or Else
All numbers will be rounded for simplification.
Q3 Sales were $500,000
Stores were a total of 585 Boots Stores.
Assuming 70% of sales came from the stores
$500,000 X 70% equals $350,000/585 stores equal $600 per store.
$150,000 then came from other sources.
Now perhaps the number is 60% store sales then figure $513 per store and $200,000 from other sources
For Q1 2016 there will be about 2511 stores
the former 585 Boots Stores 500 new Boots Stores, 1077 Lloyds Stores, 60 Gordon Chemist Stores and 186 Super Drug Stores =
2408 stores starting the year. All this has been reported by the company. (Following this company for 7 years I have never seen them tell a lie)
So using $600 per Store X 2400 Stores =
add back the $150,000 from other sources and well you have an approximation of what is coming.
Costco Canada sales are not in this example nor are other stores and countries that are going to be coming on line. 103 new stores in Canada
B Braun when it kicks in could add as many as 800,000 unit sales per year in the surgical kits. Even at just 25% of that, 200,000 units that is about another $5 Million for Biel next year starting sometime.
Then Germany.
Peanuts Market Cap for Biel considering the growth story here. This company is emerging from development stage to what is going to be a VERY profitable company.
Because an 11 million dollar Market Cap is a concern for a company that is a bout to go Profitable and has an FDA Clearance coming? Biel is going to go monster!!
There is NO truth in the Post there is NO reverse split for Biel coming anytime soon. Totally false and made up.
Peter has cried wolf on the Reverse split thing one too many times. No reverse split for Biel.
At the longest we should all be happy by the end of Q1
You forget the frustration of the last 7 years and you forget it took 18 months just to get the the new order finalized. That is all frustrating. Relax FDA is coming and the time frame is---- wait for it-----soon.
2511 Stores and Climbing $$$$$$$
Never known the CEO or Company to tell in lie in 7 years
But I do know a liar.
Voted MOST irrelevant post of the Day!!!
Perhaps of the year!!
Biel is going profitable.
Get you some!!
POSTAL POSTING Biel will prevail!!
LOVE THE SMELL OF PROFIT 2016 !$$$! ---
OH and that Pesky FDA thingy!!
Yes, going profitable and that PESKY FDA Thingy!~!
No Merit to this post about Biel
Survey Says----- post is a LIE